CompletedNCT00475137
Lamotrigine alone or with an antidepressant for bipolarity type II depression
About this title
Read the official source — NCT00475137Medication studyAges 17–70Canada
Understand this study
Who was this study for?
This study was for people with type II bipolarity. Listed age limits: 17 years to 70 years. Other eligibility criteria applied.
- Listed locations
- VancouverSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateDecember 2007
- Recruitment status
- Completed
- Enrollment listed in the registry
- 15
- Sponsor
- University of British Columbia
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Canada
- Age range
- From 17 Years to 70 Years
- Official registry ID
- NCT00475137
- Official title
Show the full official title
A Randomized, Single-Blind Comparison of Lamotrigine Add-on Versus Switch to Lamotrigine Monotherapy in the Treatment of Bipolar II Depression Unresponsive to Antidepressant Treatment
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Vancouver
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of British Columbia, a university.
Did this study involve medication?
Yes. The study involved medication, including lamotrigine.
Who was this study for?
This study was for people with type II bipolarity. Listed age limits: 17 years to 70 years. Other eligibility criteria applied.
